- Home
- XPOF vs MREO Comparison
XPOF vs MREO Comparison
Compare XPOF & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPOF
- MREO
- Stock Information
- Founded
- XPOF 2017
- MREO 2015
- Country
- XPOF United States
- MREO United Kingdom
- Employees
- XPOF N/A
- MREO N/A
- Industry
- XPOF Services-Misc. Amusement & Recreation
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- XPOF Consumer Discretionary
- MREO Health Care
- Exchange
- XPOF Nasdaq
- MREO Nasdaq
- Market Cap
- XPOF 302.9M
- MREO 281.6M
- IPO Year
- XPOF 2021
- MREO N/A
- Fundamental
- Price
- XPOF $8.93
- MREO $1.85
- Analyst Decision
- XPOF Buy
- MREO Strong Buy
- Analyst Count
- XPOF 7
- MREO 5
- Target Price
- XPOF $12.93
- MREO $7.40
- AVG Volume (30 Days)
- XPOF 598.6K
- MREO 919.1K
- Earning Date
- XPOF 11-06-2025
- MREO 11-11-2025
- Dividend Yield
- XPOF N/A
- MREO N/A
- EPS Growth
- XPOF N/A
- MREO N/A
- EPS
- XPOF N/A
- MREO N/A
- Revenue
- XPOF $316,841,000.00
- MREO $500,000.00
- Revenue This Year
- XPOF N/A
- MREO N/A
- Revenue Next Year
- XPOF $3.45
- MREO $55.50
- P/E Ratio
- XPOF N/A
- MREO N/A
- Revenue Growth
- XPOF N/A
- MREO N/A
- 52 Week Low
- XPOF $6.64
- MREO $1.47
- 52 Week High
- XPOF $18.87
- MREO $4.72
- Technical
- Relative Strength Index (RSI)
- XPOF 52.18
- MREO 57.48
- Support Level
- XPOF $8.10
- MREO $1.68
- Resistance Level
- XPOF $8.78
- MREO $1.83
- Average True Range (ATR)
- XPOF 0.36
- MREO 0.07
- MACD
- XPOF 0.07
- MREO 0.02
- Stochastic Oscillator
- XPOF 88.71
- MREO 90.48
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).